Advanced search×

Interferon alfa in the treatment of Philadelphia-negative chronic myeloproliferative neoplasms.

Hans Carl Hasselbalch, Jean-Jacques Kiladjian, and Richard T Silver

J Clin Oncol 29(18):e564-5 (2011) PMID 21576637

DOI: 10.1200/JCO.2011.35.6238
Version: za2963e q8zaa q8zbb q8zc7 q8zde q8zec q8zf5 q8zg3
View PDF

Similar articles you may find interesting…

  1. Superior retinaculoplasty for recurrent dislocation of peroneal tendons.
    Nobuo N Adachi, Kohei K Fukuhara, ... Mitsuo M Ochi

    Foot Ankle Int 27(12):1074-8 (2006) PMID 17207435

    This study demonstrated that the described repair successfully treated patients with symptomatic dislocation of the peroneal tendon and should be considered for this pathology....
  2. Comparison of vancomycin and teicoplanin trough serum levels in patients with infected orthopedic devices: new data for old therapies.
    Lemaire

    J Infect Chemother 17(3):370-4 (2011) PMID 21053041

    We compared retrospectively vancomycin and teicoplanin trough serum levels after loading doses and, subsequently, after high daily doses, in 52 patients (26 in each group) who had developed infections after implantation of an orthopedic device. The target trough serum level was >25 mg/l. Trough lev...
  3. Persistence of cytogenetic abnormalities at complete remission after induction in patients with acute myeloid leukemia: prognostic significa...
    Yiming Chen, Jorge Cortes, ... Farhad Ravandi

    J Clin Oncol 29(18):2507-13 (2011) PMID 21555694

    PURPOSE To determine the prognostic impact of persistent cytogenetic abnormalities at complete remission (CR) on relapse-free survival (RFS) and overall survival (OS) in patients with acute myeloid leukemia (AML) and to examine the potential role of allogeneic stem-cell transplantati...